Our findings that augmented expression of SOD2 mitigated aneurysm progression and rupture in experimental AAA elucidated the pivotal role of this antioxidant enzyme and revealed additional regulatory pathways downstream of its activities. The gene discussed is SOD2; the disease is triple-A syndrome.